Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03016468
Status:
WITHDRAWN
Last Update Posted:
2017-04-11
First Post:
2017-01-06
Brief Title:
Safety of Transition From Selexipag to Remodulin Then Oral Treprostinil in Symptomatic Adult PAH
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-09
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-06
First Submit QC Date:
January 6 2017
Study First Post Date:
2017-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-07
Last Update Post Date:
2017-04-11
Last Update Post Date Type:
ACTUAL